This is a problem as connections cannot be relied on geometrically and presents a challenge particularly for DfMA solutions and other situations where small tolerances are required.. Our response is to:.

Our industry-leading approach to MMC has developed over the years to consider ways to maximise the productivity of both off-site and on-site construction works to achieve better project outcomes for our clients.. Much of our thinking has been published on our website, particularly in our series of books about Construction Platforms, including the recently updated.Delivery Platforms for Government Assets.

The concept of a platform approach to DfMA (P-DfMA) has been adopted by the UK Government, particularly the Infrastructure and Projects Authority (IPA), who have said they will mandate construction platforms by 2023 for all social infrastructure..The pre-manufactured components of platform construction (P-DfMA) systems are specifically designed to be standardised and mass-produced by a wide supply chain, like the mechanical components of a car, to deliver the greatest possible factory efficiency and economies of scale..The components can be easily transported and moved, and they fit together quickly and simply on site with the least amount of handling.

Platform construction systems are designed to be flexible and customisable to avoid limiting design freedom and allow massing, form and aesthetic treatments to be considered on a plot-specific basis.. Driving value with MMC and P-DfMA.Construction platforms are an example of an approach to DfMA that relies on both off-site and on-site construction works, bringing the best aspects of both.

The division of fabrication and assembly tasks has been carefully considered to maximise the efficiency of both factory prefabrication and on-site assembly.

This is a key aspect of Bryden Wood’s.You can also learn about our approach to data centre design.Accelerating Pharma was the stated purpose of our first venture in bringing people together to help find solutions that would unlock huge potential.

Those who joined us came from several leading pharmaceutical companies united, in part by a frustration that the world cannot see an opportunity that to some seems so obvious and enticing: -.The combination of process intensification, modularity and automation could transform the industrialisation, commercialisation, sustainability of, and access to, small molecule medicines..

The potential benefits of deploying these platforms are huge.Modelling deployment over a 10-year period demonstrates the opportunity of billions in improved cashflow from the reduction in capital wastage and the delivery of products more quickly to market.